PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells

Molecular and Cellular Biology

Volumn 22, Issue 15, 2002, Pages 5281-5295

  Ryo, Akihide ^a   Liou, Yih Cherng ^a   Wulf, Gerburg ^a   Nakamura, Masafumi ^a   Lee, Sam W ^a   Lu, Kun Ping ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ISOMERASE; PEPTIDYLPROLYL ISOMERASE PIN1; PROLINE; SERINE; THREONINE; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL TRANSFORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; INHIBITION KINETICS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE NEU; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

BASE SEQUENCE; BREAST; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDYLPROLYL ISOMERASE; PHENOTYPE; PROMOTER REGIONS (GENETICS); RAS PROTEINS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION;

ANIMALIA;

EID: 0036315162     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.15.5281-5295.2002     Document Type: Article

References (63)

1. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
2. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation
3. Tyrosine kinase signalling in breast cancer: Tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer
4. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells
5. Cyclin D1 protein expression and function in human breast cancer
6. Oncogenic kinase signalling
7. 1 arrest induced by deprivation of epidermal growth factor
8. Additive effects of c-erbB-2, c-Ha-Ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells
9. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
10. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway
11. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth
12. K-Ras modulates the cell cycle via both positive and negative regulatory pathways
13. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
14. Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain
15. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
16. Invasive phenotype of MCF10A cells overexpressing c-Ha-Ras and c-erbB-2 oncogenes
17. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1
18. The hallmarks of cancer
19. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
20. Function of a human cyclin gene as an oncogene
21. Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis
22. Prolyl isomerase and nuclear function
23. A simple and rapid method for generating a deletion by PCR
24. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
25. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F
26. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum
27. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway
28. Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
29. Loss of Pin1 function in the mouse resembles the cyclin D1-null phenotypes
30. A human peptidyl-prolyl isomerase essential for regulation of mitosis
31. Pinning down the proline-directed phosphorylation signaling
32. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
33. Role of WW domain phosphorylation in regulating its phosphoserine-binding activity and the Pin1 function
34. A function of WW domains as phosphoserine- or phosphothreonine-binding modules
35. pRb and E2f-1 in mouse development and tumorigenesis
36. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-Neu oncogene
37. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
38. An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F
39. The Rb/E2F pathway and cancer
40. Regulation of the cyclin E gene by transcription factor E2F1
41. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F
42. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells
43. Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent
44. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC
45. Inhibition of lung cancer proliferation by antisense cyclin D
46. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins
47. Cancer cell cycles
48. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
49. Coexpression of MMTV/v-Ha-Ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo
50. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/Neu oncogene
51. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10
52. Pin1 acts catalytically to promote a conformational change in Cdc25
53. Sibling rivalry in the E2F family
54. Ras activation in human breast cancer
55. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
56. The retinoblastoma protein and cell cycle control
57. Target gene specificity of E2F and pocket protein family members in living cells
58. Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene
59. Sequence-specific and phosphorylation-dependent proline isomerization: A potential mitotic regulatory mechanism
60. Specific protection against breast cancers by cyclin D1 ablation
61. E2F-1: A proliferative marker of breast neoplasia
62. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins
63. Phosphorylation-dependent prolyl isomerization: A novel signaling regulatory mechanism